Fenofibrate Patent Expiration
Fenofibrate is Used for managing high levels of cholesterol and triglycerides in the blood. It was first introduced by Abbvie Inc
Fenofibrate Patents
Given below is the list of patents protecting Fenofibrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Antara (micronized) | US9314447 | Reduced dose pharmaceutical compositions of fenofibrate | May 31, 2033 | Lupin |
| Antara (micronized) | US8026281 | Treating metabolic syndrome with fenofibrate |
Apr 22, 2025
(Expired) | Lupin |
| Fenoglide | US7658944 | Solid dosage form comprising a fibrate |
Dec 09, 2024
(Expired) | Salix |
| Fenoglide | US8124125 | Solid dosage form comprising a fibrate |
Oct 01, 2024
(Expired) | Salix |
| Fenoglide | US8481078 | Solid dosage form comprising a fibrate |
Oct 01, 2024
(Expired) | Salix |
| Fenoglide | US9173847 | Tablet comprising a fibrate |
Oct 01, 2024
(Expired) | Salix |
| Tricor | US7276249 | Nanoparticulate fibrate formulations |
Feb 21, 2023
(Expired) | Abbvie |
| Tricor | US7320802 | Methods of treatment using nanoparticulate fenofibrate compositions |
Feb 21, 2023
(Expired) | Abbvie |
| Triglide | US6696084 | Spray drying process and compositions of fenofibrate |
Sep 11, 2021
(Expired) | Skyepharma Ag |
| Tricor | US6375986 | Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
Sep 21, 2020
(Expired) | Abbvie |
| Antara (micronized) | US7101574 | Pharmaceutical composition containing fenofibrate and the preparation method |
Aug 20, 2020
(Expired) | Lupin |
| Antara (micronized) | US7863331 | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
Aug 08, 2020
(Expired) | Lupin |
| Tricor | US6074670 | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
Jan 09, 2018
(Expired) | Abbvie |
| Tricor | US6277405 | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
Jan 09, 2018
(Expired) | Abbvie |
| Tricor | US6589552 | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
Jan 09, 2018
(Expired) | Abbvie |
| Tricor | US6652881 | Fenofibrate pharmaceutical composition having high bioavailability |
Jan 09, 2018
(Expired) | Abbvie |
| Tricor | US7037529 | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
Jan 09, 2018
(Expired) | Abbvie |
| Tricor | US7041319 | Fenofibrate pharmaceutical composition having high bioavailabilty |
Jan 09, 2018
(Expired) | Abbvie |
| Lipofen | US5545628 | Pharmaceutical composition containing fenofibrate |
Jan 10, 2015
(Expired) | Cipher Pharms Inc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Fenofibrate's patents.
Latest Legal Activities on Fenofibrate's Patents
Given below is the list recent legal activities going on the following patents of Fenofibrate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 22 Jul, 2019 | US7320802(Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 02 Apr, 2019 | US7276249(Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Oct, 2017 | US7037529(Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Oct, 2017 | US7041319(Litigated) |
| File Marked Found | 18 Apr, 2016 | US6652881 |
| File Marked Found | 18 Apr, 2016 | US6589552(Litigated) |
| File Marked Found | 07 Apr, 2016 | US6589552(Litigated) |
| File Marked Found | 07 Apr, 2016 | US6652881 |
| File Marked Found | 05 Apr, 2016 | US6589552(Litigated) |
| File Marked Found | 05 Apr, 2016 | US6652881 |
Fenofibrate's Family Patents
Explore Our Curated Drug Screens
Fenofibrate Generic API Manufacturers
Several generic applications have been filed for Fenofibrate. The first generic version for Fenofibrate was by Rhodes Pharmaceuticals Lp and was approved on Apr 9, 2002. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Nov 13, 2024.
Given below is the list of companies who have filed for Fenofibrate generic, along with the locations of their manufacturing plants worldwide.
1. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 5 different strengths of generic version for Fenofibrate. Out of these 67mg version comes by the name FENOFIBRATE (MICRONIZED), 134mg version comes by the name FENOFIBRATE (MICRONIZED), 200mg version comes by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 160MG | tablet | Prescription | ORAL | AB | Jul 23, 2018 |
| 54MG | tablet | Prescription | ORAL | AB | Jul 23, 2018 |
| 67MG | capsule | Prescription | ORAL | AB | Sep 10, 2018 |
| 134MG | capsule | Prescription | ORAL | AB | Sep 10, 2018 |
| 200MG
(reference standard) | capsule | Prescription | ORAL | AB | Sep 10, 2018 |
Manufacturing Plant Locations New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
2. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 7 different strengths of generic version for Fenofibrate. Out of these 200mg version comes by the name FENOFIBRATE (MICRONIZED), 134mg version comes by the name FENOFIBRATE (MICRONIZED), 67mg version comes by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 145MG | tablet | Prescription | ORAL | AB | Aug 9, 2019 |
| 48MG | tablet | Prescription | ORAL | AB | Aug 9, 2019 |
| 54MG | tablet | Discontinued | ORAL | N/A | Jan 17, 2020 |
| 160MG | tablet | Discontinued | ORAL | N/A | Jan 17, 2020 |
| 200MG | capsule | Prescription | ORAL | AB | Oct 19, 2020 |
| 134MG | capsule | Prescription | ORAL | AB | Oct 19, 2020 |
| 67MG | capsule | Prescription | ORAL | AB | Oct 19, 2020 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
3. AMNEAL
Amneal Pharmaceuticals Llc has filed for 4 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 48MG | tablet | Prescription | ORAL | AB | Feb 9, 2018 |
| 145MG | tablet | Prescription | ORAL | AB | Feb 9, 2018 |
| 160MG | tablet | Prescription | ORAL | AB | Mar 19, 2018 |
| 54MG | tablet | Prescription | ORAL | AB | Mar 19, 2018 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
4. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | capsule | Prescription | ORAL | AB | Apr 30, 2018 |
| 67MG | capsule | Prescription | ORAL | AB | Apr 30, 2018 |
| 134MG | capsule | Prescription | ORAL | AB | Apr 30, 2018 |
5. APOTEX
Apotex Inc has filed for 2 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 43MG | capsule | Prescription | ORAL | AB | Jul 26, 2013 |
| 130MG | capsule | Prescription | ORAL | AB | Jul 26, 2013 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
6. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 48MG | tablet | Prescription | ORAL | AB | May 5, 2016 |
| 145MG
(reference standard) | tablet | Prescription | ORAL | AB | May 5, 2016 |
| 160MG | tablet | Prescription | ORAL | AB | Sep 27, 2022 |
| 54MG | tablet | Prescription | ORAL | AB | Sep 27, 2022 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
7. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 134MG | capsule | Prescription | ORAL | AB | Sep 20, 2021 |
| 200MG | capsule | Prescription | ORAL | AB | Sep 20, 2021 |
| 67MG | capsule | Prescription | ORAL | AB | Sep 20, 2021 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
8. AUSTARPHARMA
Austarpharma Llc has filed for 4 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Austarpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 54MG | tablet | Prescription | ORAL | AB | Dec 19, 2017 |
| 160MG | tablet | Prescription | ORAL | AB | Dec 19, 2017 |
| 48MG | tablet | Prescription | ORAL | AB | Feb 10, 2021 |
| 145MG | tablet | Prescription | ORAL | AB | Feb 10, 2021 |
Manufacturing Plant Locations New
Austarpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Austarpharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
9. CHARTWELL
Chartwell Life Molecules Llc has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Chartwell.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 67MG | capsule | Prescription | ORAL | AB | Jan 31, 2024 |
| 134MG | capsule | Prescription | ORAL | AB | Jan 31, 2024 |
| 200MG | capsule | Prescription | ORAL | AB | Jan 31, 2024 |
Manufacturing Plant Locations New
Chartwell's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Chartwell as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||
10. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 54MG | tablet | Prescription | ORAL | AB | Feb 11, 2019 |
| 160MG | tablet | Prescription | ORAL | AB | Feb 11, 2019 |
11. CIPLA
Cipla Ltd has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 145MG | tablet | Prescription | ORAL | AB | Dec 15, 2016 |
| 48MG | tablet | Prescription | ORAL | AB | Dec 15, 2016 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
12. CREEKWOOD PHARMS
Creekwood Pharmaceuticals Llc has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Creekwood Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | tablet | Prescription | ORAL | AB | Sep 7, 2023 |
| 120MG | tablet | Prescription | ORAL | AB | Sep 7, 2023 |
13. DR REDDYS
Dr Reddys Laboratories Inc has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 54MG | tablet | Prescription | ORAL | AB | Sep 6, 2019 |
| 160MG | tablet | Prescription | ORAL | AB | Sep 6, 2019 |
14. DR REDDYS LABS SA
Dr Reddys Laboratories Sa has filed for 2 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 43MG | capsule | Prescription | ORAL | AB | Mar 1, 2012 |
| 130MG | capsule | Prescription | ORAL | AB | Mar 1, 2012 |
15. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | capsule | Prescription | ORAL | AB | Apr 7, 2017 |
| 134MG | capsule | Prescription | ORAL | AB | Apr 7, 2017 |
| 67MG | capsule | Prescription | ORAL | AB | Apr 7, 2017 |
16. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 48MG | tablet | Prescription | ORAL | AB | Jul 12, 2016 |
| 145MG | tablet | Prescription | ORAL | AB | Jul 12, 2016 |
17. IMPAX LABS
Impax Laboratories Inc has filed for 5 different strengths of generic version for Fenofibrate. Out of these 200mg version comes by the name FENOFIBRATE (MICRONIZED), 134mg version comes by the name FENOFIBRATE (MICRONIZED), 67mg version comes by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Impax Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | capsule | Discontinued | ORAL | N/A | Oct 27, 2003 |
| 134MG | capsule | Discontinued | ORAL | N/A | Oct 27, 2003 |
| 67MG | capsule | Discontinued | ORAL | N/A | Oct 27, 2003 |
| 54MG | tablet | Prescription | ORAL | AB | Mar 26, 2008 |
| 160MG
(reference standard) | tablet | Prescription | ORAL | AB | Mar 26, 2008 |
18. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Invagen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 67MG | capsule | Discontinued | ORAL | N/A | Mar 28, 2017 |
| 200MG | capsule | Discontinued | ORAL | N/A | Mar 28, 2017 |
| 134MG | capsule | Discontinued | ORAL | N/A | Mar 28, 2017 |
19. LUPIN LTD
Lupin Ltd has filed for 4 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 48MG | tablet | Prescription | ORAL | AB | Dec 23, 2011 |
| 145MG | tablet | Prescription | ORAL | AB | Dec 23, 2011 |
| 54MG | tablet | Prescription | ORAL | AB | Aug 17, 2015 |
| 160MG | tablet | Prescription | ORAL | AB | Aug 17, 2015 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
20. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 145MG | tablet | Prescription | ORAL | AB | Nov 13, 2024 |
| 48MG | tablet | Prescription | ORAL | AB | Nov 13, 2024 |
21. MANKIND PHARMA
Mankind Pharma Ltd has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Mankind Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 54MG | tablet | Prescription | ORAL | AB | Jun 12, 2020 |
| 160MG | tablet | Prescription | ORAL | AB | Jun 12, 2020 |
Manufacturing Plant Locations New
Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
22. MYLAN
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 107MG | tablet | Discontinued | ORAL | N/A | Dec 29, 2005 |
| 54MG | tablet | Discontinued | ORAL | N/A | Oct 25, 2007 |
| 160MG | tablet | Discontinued | ORAL | N/A | Oct 25, 2007 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
| Canada |
| |||||||||||||||||
| Ireland |
| |||||||||||||||||
23. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 145MG | tablet | Prescription | ORAL | AB | Dec 7, 2012 |
| 48MG | tablet | Prescription | ORAL | AB | Dec 7, 2012 |
| 40MG | tablet | Prescription | ORAL | AB | Jun 23, 2016 |
| 120MG
(reference standard) | tablet | Prescription | ORAL | AB | Jun 23, 2016 |
24. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 2 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 43MG | capsule | Discontinued | ORAL | N/A | Jan 10, 2013 |
| 130MG | capsule | Discontinued | ORAL | N/A | Jan 10, 2013 |
25. NOVAST LABS
Novast Laboratories Ltd has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | capsule | Discontinued | ORAL | N/A | Apr 19, 2019 |
| 67MG | capsule | Discontinued | ORAL | N/A | Apr 19, 2019 |
| 134MG | capsule | Discontinued | ORAL | N/A | Apr 19, 2019 |
26. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 145MG | tablet | Prescription | ORAL | AB | Aug 28, 2018 |
| 48MG | tablet | Prescription | ORAL | AB | Aug 28, 2018 |
27. REYOUNG
Reyoung Corporation has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Reyoung.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 134MG | capsule | Prescription | ORAL | AB | Nov 16, 2017 |
| 67MG | capsule | Prescription | ORAL | AB | Nov 16, 2017 |
| 200MG | capsule | Prescription | ORAL | AB | Nov 16, 2017 |
28. RHODES PHARMS
Rhodes Pharmaceuticals Lp has filed for 5 different strengths of generic version for Fenofibrate. Out of these 134mg version comes by the name FENOFIBRATE (MICRONIZED), 200mg version comes by the name FENOFIBRATE (MICRONIZED), 67mg version comes by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Rhodes Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 134MG | capsule | Prescription | ORAL | AB | Apr 9, 2002 |
| 200MG | capsule | Prescription | ORAL | AB | Apr 9, 2002 |
| 67MG | capsule | Prescription | ORAL | AB | Sep 3, 2002 |
| 160MG | tablet | Prescription | ORAL | AB | May 13, 2005 |
| 54MG | tablet | Prescription | ORAL | AB | May 13, 2005 |
29. RISING
Rising Pharma Holdings Inc has filed for 7 different strengths of generic version for Fenofibrate. Out of these 134mg version comes by the name FENOFIBRATE (MICRONIZED), 200mg version comes by the name FENOFIBRATE (MICRONIZED), 67mg version comes by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 134MG | capsule | Discontinued | ORAL | N/A | Oct 23, 2012 |
| 200MG | capsule | Discontinued | ORAL | N/A | Oct 23, 2012 |
| 67MG | capsule | Discontinued | ORAL | N/A | Oct 23, 2012 |
| 54MG | tablet | Prescription | ORAL | AB | Aug 17, 2018 |
| 160MG | tablet | Prescription | ORAL | AB | Aug 17, 2018 |
| 48MG | tablet | Prescription | ORAL | AB | Mar 18, 2020 |
| 145MG | tablet | Prescription | ORAL | AB | Mar 18, 2020 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
30. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 145MG | tablet | Prescription | ORAL | AB | Sep 7, 2017 |
| 48MG | tablet | Discontinued | ORAL | N/A | Sep 7, 2017 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
31. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 5 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 54MG | tablet | Discontinued | ORAL | N/A | Oct 31, 2005 |
| 160MG | tablet | Discontinued | ORAL | N/A | Oct 31, 2005 |
| 107MG | tablet | Prescription | ORAL | N/A | Oct 31, 2005 |
| 43MG | capsule | Prescription | ORAL | AB | Oct 31, 2014 |
| 130MG | capsule | Prescription | ORAL | AB | Oct 31, 2014 |
32. TORRENT
Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 134MG | capsule | Prescription | ORAL | AB | Jun 26, 2018 |
| 67MG | capsule | Prescription | ORAL | AB | Jun 26, 2018 |
| 200MG | capsule | Prescription | ORAL | AB | Jun 26, 2018 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
| United States |
| |||||||||||
33. VALEANT PHARMS NORTH
Valeant Pharmaceuticals North America Llc has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Valeant Pharms North.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 145MG | tablet | Prescription | ORAL | AB | Apr 5, 2012 |
| 48MG | tablet | Prescription | ORAL | AB | Apr 5, 2012 |
34. YICHANG HUMANWELL
Yichang Humanwell Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Yichang Humanwell.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 160MG | tablet | Prescription | ORAL | AB | Apr 24, 2024 |
| 54MG | tablet | Prescription | ORAL | AB | Apr 24, 2024 |
Manufacturing Plant Locations New
Yichang Humanwell's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Yichang Humanwell as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| China |
| |||